DVA Stock Recent News
DVA LATEST HEADLINES
DENVER , Aug. 6, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended June 30, 2024. "On behalf of all the teammates who provide life-saving care to our patients, I am grateful for the opportunity to report another positive quarter for DaVita," said Javier Rodriguez, CEO of DaVita Inc. "We continue to enhance our clinical capabilities while optimizing our revenue operations and cost structure.
Improvement in RPT and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the second quarter.
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised to gain.
In the latest trading session, DaVita HealthCare (DVA) closed at $136.47, marking a -1.93% move from the previous day.
As the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.
The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.
DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00 p.m. Eastern Time.
DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032 Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory surgery centers, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2024-2032